share_log

Minim | 8-K: Current report

Minim | 8-K:重大事件

美股sec公告 ·  2023/12/29 00:00
Moomoo AI 已提取核心信息
On December 28, 2023, Minim, Inc., a Delaware-incorporated company listed on the Nasdaq Capital Market under the trading symbol MINM, announced significant changes to its Board of Directors. The company expanded its Board from four to seven directors, electing Avraham Ben-Tzvi, Matthew C. McMurdo, and David E. Lazar as new directors. The expansion and appointments are part of the company's governance and strategic growth plans. Ben-Tzvi brings extensive legal expertise, having founded ABZ Law Office and served as Chief Legal Officer at Purple Biotech Ltd. McMurdo, with a background in corporate law, is the Managing Member of McMurdo Law Group, LLC, and has held various legal positions in the past. Lazar, the CEO of Titan Pharmaceuticals Inc. and...Show More
On December 28, 2023, Minim, Inc., a Delaware-incorporated company listed on the Nasdaq Capital Market under the trading symbol MINM, announced significant changes to its Board of Directors. The company expanded its Board from four to seven directors, electing Avraham Ben-Tzvi, Matthew C. McMurdo, and David E. Lazar as new directors. The expansion and appointments are part of the company's governance and strategic growth plans. Ben-Tzvi brings extensive legal expertise, having founded ABZ Law Office and served as Chief Legal Officer at Purple Biotech Ltd. McMurdo, with a background in corporate law, is the Managing Member of McMurdo Law Group, LLC, and has held various legal positions in the past. Lazar, the CEO of Titan Pharmaceuticals Inc. and Custodian Ventures LLC, offers a wealth of experience in financial and operations management. The new directors' terms will expire at Minim's 2024 annual meeting of stockholders. At the time of their election, none of the new directors were appointed to any Board committees. The Board has deemed Ben-Tzvi and McMurdo as independent directors, while Lazar, intended to be engaged as an executive officer, is not considered independent.
2023年12月28日,在纳斯达克资本市场上市的特拉华州注册公司Minim, Inc. 宣布对董事会进行重大调整。该公司将董事会从四名董事扩大到七名,选举阿夫拉姆·本-茨维、马修·麦克默多和戴维·拉扎尔为新董事。扩张和任命是公司治理和战略增长计划的一部分。Ben-Tzvi拥有丰富的法律专业知识,曾创立ABZ律师事务所,并在紫色生物技术有限公司担任首席法务官。麦克默多具有公司法背景,是麦克默多律师集团有限责任公司的管理成员,过去曾担任过各种法律职务。泰坦制药公司和Custodian Ventures LLC的首席执行官拉扎尔在财务和运营管理方面拥有丰富的经验。新董事的任期将在Minim的2024年年度股东大会上到期。在他们当选时,没有一位新董事被任命为任何董事会委员会的成员。董事会已将Ben-Tzvi和McMurdo视为独立董事,而打算担任执行官的拉扎尔不被视为独立董事。
2023年12月28日,在纳斯达克资本市场上市的特拉华州注册公司Minim, Inc. 宣布对董事会进行重大调整。该公司将董事会从四名董事扩大到七名,选举阿夫拉姆·本-茨维、马修·麦克默多和戴维·拉扎尔为新董事。扩张和任命是公司治理和战略增长计划的一部分。Ben-Tzvi拥有丰富的法律专业知识,曾创立ABZ律师事务所,并在紫色生物技术有限公司担任首席法务官。麦克默多具有公司法背景,是麦克默多律师集团有限责任公司的管理成员,过去曾担任过各种法律职务。泰坦制药公司和Custodian Ventures LLC的首席执行官拉扎尔在财务和运营管理方面拥有丰富的经验。新董事的任期将在Minim的2024年年度股东大会上到期。在他们当选时,没有一位新董事被任命为任何董事会委员会的成员。董事会已将Ben-Tzvi和McMurdo视为独立董事,而打算担任执行官的拉扎尔不被视为独立董事。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息